Muscular Dystrophy
Muscular Dystrophies: Recent Insights - May 26, 2015
CDC and Related Info
Advances in Muscular Dystrophies.
Kang PB et al. JAMA Neurol 2015 May 18.
Kang PB et al. JAMA Neurol 2015 May 18.
A comprehensive genetic diagnosis of Chinese muscular dystrophy and congenital myopathy patients by targeted next-generation sequencing.
Dai Y et al. Neuromuscul. Disord. 2015 Mar 17.
Dai Y et al. Neuromuscul. Disord. 2015 Mar 17.
Nutrition considerations in Duchenne muscular dystrophy.
Davis Jillian et al. Nutr Clin Pract 2015 May 14.
Davis Jillian et al. Nutr Clin Pract 2015 May 14.
Cell therapy in Duchenne muscular dystrophy treatment: clinical trials overview.
Bajek A et al. Crit. Rev. Eukaryot. Gene Expr. 2015 (1) 1-11
Bajek A et al. Crit. Rev. Eukaryot. Gene Expr. 2015 (1) 1-11
Efficacy of idebenone in Duchenne muscular dystrophy.
Mercuri E et al. Lancet 2015 May 2. (9979) 1704-6
Mercuri E et al. Lancet 2015 May 2. (9979) 1704-6
Congenital muscular dystrophies: New evidence-based guidelines for the diagnosis and management of this evolving group of muscle disorders.
McMillan HJ et al. Muscle Nerve 2015 Jun (6) 791-2
McMillan HJ et al. Muscle Nerve 2015 Jun (6) 791-2
Muscular Dystrophies: Recent Public Health and Genomic Insights - April 14, 2015
CDC and Related Info
Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
Kang PB et al. Neurology 2015 Mar 31. (13) 1369-78
Kang PB et al. Neurology 2015 Mar 31. (13) 1369-78
CDC Key Findings: Population-based prevalence of Duchenne and Becker Muscular Dystrophies in the United States
First population-based prevalence on Duchenne and Becker Muscular Dystrophy in the United States by race and ethnicity
First population-based prevalence on Duchenne and Becker Muscular Dystrophy in the United States by race and ethnicity
CDC paper: Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
Paul A. Romitti, et al. Pediatrics, February 2015
Paul A. Romitti, et al. Pediatrics, February 2015
CDC Muscular Dystrophy Research
CDC's Muscular Dystrophy Surveillance Tracking and Research Network is the only population-based muscular dystrophy tracking program in the United States
CDC's Muscular Dystrophy Surveillance Tracking and Research Network is the only population-based muscular dystrophy tracking program in the United States
Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies.
Pettygrove Sydney et al. Muscle Nerve 2014 Jun (6) 814-21
Pettygrove Sydney et al. Muscle Nerve 2014 Jun (6) 814-21
Online self-report data for Duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefits.
Wang Richard T et al. PLoS Curr 2014
Wang Richard T et al. PLoS Curr 2014
The TREAT-NMD DMD Global database: Analysis of more than 7000 Duchenne muscular dystrophy mutations.
Bladen Catherine L et al. Hum. Mutat. 2015 Jan 21.
Bladen Catherine L et al. Hum. Mutat. 2015 Jan 21.
Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.
Tedesco Francesco Saverio et al. Chromosome Res. 2015 Jan 18.
Tedesco Francesco Saverio et al. Chromosome Res. 2015 Jan 18.
Duchenne muscular dystrophy gene therapy in the canine model.
Duan Dongsheng et al. Hum Gene Ther Clin Dev 2015 Jan 14.
Duan Dongsheng et al. Hum Gene Ther Clin Dev 2015 Jan 14.
Prevalence of muscular dystrophies: a systematic literature review.
Theadom Alice et al. Neuroepidemiology 2014 (3-4) 259-68
Theadom Alice et al. Neuroepidemiology 2014 (3-4) 259-68
Muscular Dystrophies: Recent Public Health and Genomic Insights - February 17, 2015
CDC Key Findings: Population-based prevalence of Duchenne and Becker Muscular Dystrophies in the United States
First population-based prevalence on Duchenne and Becker Muscular Dystrophy in the United States by race and ethnicity
First population-based prevalence on Duchenne and Becker Muscular Dystrophy in the United States by race and ethnicity
CDC paper: Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
Paul A. Romitti, et al. Pediatrics, February 2015
Paul A. Romitti, et al. Pediatrics, February 2015
CDC Muscular Dystrophy Research
CDC's Muscular Dystrophy Surveillance Tracking and Research Network is the only population-based muscular dystrophy tracking program in the United States
CDC's Muscular Dystrophy Surveillance Tracking and Research Network is the only population-based muscular dystrophy tracking program in the United States
Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies.
Pettygrove Sydney et al. Muscle Nerve 2014 Jun (6) 814-21
Pettygrove Sydney et al. Muscle Nerve 2014 Jun (6) 814-21
Online self-report data for duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefits.
Wang Richard T et al. PLoS Curr 2014
Wang Richard T et al. PLoS Curr 2014
The TREAT-NMD DMD Global database: Analysis of more than 7000 Duchenne Muscular Dystrophy mutations.
Bladen Catherine L et al. Hum. Mutat. 2015 Jan 21.
Bladen Catherine L et al. Hum. Mutat. 2015 Jan 21.
Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.
Tedesco Francesco Saverio et al. Chromosome Res. 2015 Jan 18.
Tedesco Francesco Saverio et al. Chromosome Res. 2015 Jan 18.
Duchenne muscular dystrophy gene therapy in the canine model.
Duan Dongsheng et al. Hum Gene Ther Clin Dev 2015 Jan 14.
Duan Dongsheng et al. Hum Gene Ther Clin Dev 2015 Jan 14.
Prevalence of muscular dystrophies: a systematic literature review.
Theadom Alice et al. Neuroepidemiology 2014 (3-4) 259-68
Theadom Alice et al. Neuroepidemiology 2014 (3-4) 259-68
Muscular Dystrophy: Recent Genomic Insights - September 4, 2014
CDC information: Muscular dystrophies are a group of genetic disorders that result in muscle weakness over time
CDC information: Muscular dystrophy- Kevin's Story
Our beautiful sons could die before us, by Nick Taussig, The Guardian, Aug 15
by Nick Taussig, The Guardian, Aug 15 Recent insights
Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA.
Chengzu Long et al. Science, August 14, 2014
Chengzu Long et al. Science, August 14, 2014
Therapeutic prospects for CRISPR genome editing, by Phillipa Price, PHG Foundation, Aug 21
by Phillipa Price, PHG Foundation, Aug 21
.png)
No hay comentarios:
Publicar un comentario